Product Introduction:
Elmecob-D Tablet is a combination medicine used to manage type 2 diabetes mellitus along with providing Vitamin D3 supplementation. It combines Metformin Hydrochloride (1500 mg) with Sitagliptin (100 mg) and Vitamin D3 (strength may vary), aiming to control blood glucose levels and improve insulin response while supporting bone health.
Uses:
-
Management of Type 2 Diabetes Mellitus
-
Helps control blood sugar levels effectively
-
Provides Vitamin D3 supplementation for bone health and immune support
Benefit:
-
Metformin reduces hepatic glucose production and improves insulin sensitivity
-
Sitagliptin increases insulin release and decreases glucagon levels, helping maintain blood sugar balance
-
Vitamin D3 supports bone mineralization and immune function
-
Combined therapy improves glycemic control and overall health
Composition (per tablet):
-
Sitagliptin 100 mg
-
Metformin Hydrochloride 1500 mg
-
Vitamin D3 (Cholecalciferol) (strength varies)
Side Effects:
-
Gastrointestinal symptoms like nausea, vomiting, diarrhea, and abdominal discomfort
-
Possible hypoglycemia when combined with other antidiabetic drugs
-
Headache, dizziness, or allergic reactions (rare)
Consult your healthcare provider if severe or persistent side effects occur.
Safety Advice:
-
Take the tablet with meals to reduce gastrointestinal discomfort
-
Regular blood sugar monitoring is essential
-
Avoid alcohol and inform your doctor about any kidney, liver, or heart conditions
-
Not recommended during pregnancy or breastfeeding unless prescribed by a doctor
